🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with relapsed or refractory leukemia often develop resistance to c...
Status
Completed
Location
Seattle Children's Hospital
Start Date
2017-07-27
Trial ID
NCT03244306
Treatments Being Tested
This is an open-labeled, single-armed and prospective study, patients with ...
Status
Unknown
Location
Fourth Hospital of Hebei Medical University
Start Date
2020-08-01
Trial ID
NCT04556669
Treatments Being Tested
This study is a single-armed, open-label,multicenter Phase 1/2 study to eva...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2021-10-20
Trial ID
NCT05091541
Treatments Being Tested
This is an investigator-initiated, single-arm, open-label, non-randomised p...
Status
Recruiting
Location
Beijing GoBroad Hospital
Start Date
2026-03-15
Trial ID
NCT06326008
This is a single center, open-label ,phase 1/2 study to evaluate the safety...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2017-09-01
Trial ID
NCT03614858
Treatments Being Tested
Phase 1/2 umbrella study evaluates biomarker-selected dual-target CAR-T cel...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07523555
Treatments Being Tested
This is a prospective, open-label, single-arm, umbrella phase 2 clinical tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-12
Trial ID
NCT07643103
This study will evaluate safety and efficacy of a combination of 4th genera...
Status
Terminated
Location
Shenzhen Geno-Immune Medical Institute
Start Date
2026-06-01
Trial ID
NCT04430530
Treatments Being Tested
First-in-human, open-label, dose-finding and dose-expansion study of UCART2...
Status
Recruiting
Location
The University of Chicago Medical Center (UCMC)
Start Date
2022-11-01
Trial ID
NCT05607420
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of anti-CD1...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-01-14
Trial ID
NCT07166419